Tuesday, 02 January 2024 12:17 GMT

Aortic Aneurysm Market Top Players, Segments & Regional Trends By 2034


(MENAFN- Straits Research) Introduction

Straits Research released its highly anticipated report, “Global Aortic Aneurysm Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 5.60 billion in 2025 and is anticipated to grow to USD 16.20 billion by 2034, growing at a CAGR of 12.56% from 2026-2034.

Market Dynamics

The aortic aneurysm market is driven by the growing clinical emphasis on early detection and planned intervention for aneurysmal disease to reduce rupture-related mortality. Expansion of routine vascular imaging for cardiovascular risk assessment and structured surveillance programs has increased identification of asymptomatic aneurysms, supporting timely elective repair. Rising preference for minimally invasive endovascular procedures further contributes to market growth, as these approaches align with shorter recovery timelines and optimized hospital resource utilization. However, the market faces a restraint due to the complexity of procedural planning and execution associated with aortic aneurysm repair. Treatment requires advanced imaging interpretation, precise anatomical assessment, and availability of specialized vascular teams, which limits adoption in healthcare settings with constrained expertise or infrastructure. Additionally, long-term follow-up requirements and device surveillance after endovascular repair add to the procedural burden for providers and patients. Despite these challenges, the market presents a strong opportunity through the expansion of customized and modular endovascular repair solutions designed for complex anatomies. Increasing focus on treating patients with short necks, branched vessels, or irregular aortic morphology is driving demand for fenestrated and branched repair systems. Parallel growth in digital planning platforms and simulation-based procedural preparation supports wider clinical confidence in managing challenging cases. As healthcare systems continue to prioritize elective aneurysm management over emergency intervention, adoption of advanced repair technologies across specialized centers is expected to accelerate, supporting sustained market expansion over the forecast period.

Market Highlights

  • Type: Based on the Type, the thoracic aortic aneurysm (TAA) segment is anticipated to register the fastest CAGR of 13.21%.
  • Treatment: Based on Treatment, the endovascular aneurysm repair segment dominated the market with a revenue share of 55.67% in 2025.
  • Product: Based on Product, the aortic stent grafts segment dominated the aortic aneurysm market with a revenue share of 82.95% in 2025.
  • End Use: Based on End Use, the hospital segment dominated the market with a revenue share of 79.23% in 2025.
  • Regional Insights: North America held a dominant share of the global market, accounting for 47.54% in 2025.

Competitive Players

  • ai, Inc.
  • LifeTech Scientific Corporation
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • Lombard Medical
  • Boston Scientific Corporation
  • Cardiatis
  • Endospan
  • MicroPort Scientific Corporation
  • Cordis
  • Terumo Corporation
  • Medtronic
  • Cook
  • Cardinal Health
  • L. Gore & Associates, Inc.
  • Others

    Recent Developments

    October 2025: Medtronic received U.S. Food and Drug Administration (FDA) labeling approval for the Medtronic Endurant stent graft system by adding ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removing the rAAA treatment warning. This FDA labeling approval made Medtronic the first and only company to remove the rAAA warning from its stent graft system Instructions for Use (IFU), aligning innovation with real-world practices and training to empower physicians to act confidently in emergency cases.

    Segmentation

  • By Type (2026-2034)
  • Thoracic Aortic Aneurysm (TAA)
  • Abdominal Aortic Aneurysm (AAA)
  • By Treatment (2026-2034)
  • Open Surgical Repair (OSR)
  • Endovascular Aneurysm Repair (EVAR)
  • Thoracic Endovascular Aneurysm Repair (TEVAR)
  • Fenestrated Endovascular Aneurysm Repair (FEVAR)
  • Branched Endovascular Aneurysm Repair (BEVAR)
  • Hybrid procedures
  • By Product (2026-2034)
  • Aortic Stent Grafts
  • Bifurcated Stent Grafts (Standard EVAR)
  • Straight Stent Grafts (Standard TEVAR)
  • Fenestrated Stent Grafts (FEVAR)
  • Branched Stent Grafts (BEVAR)
  • Hybrid Stent Grafts
  • Aortic Surgical Grafts
  • Aortic Repair Accessory Devices
  • Guidewires
  • Diagnostic Catheters
  • Sheaths
  • Guiding Catheters
  • Molding Balloons
  • By End Use (2026-2034)
  • Hospitals
  • Ambulatory Surgery Centers (ASC)
  • Clinics

    Chat with us on WhatsApp

    MENAFN26122025004597010339ID1110527180



  • Straits Research

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

    Search